Annovis Bio
ANVS • NYSE
Annovis Bio is a biotechnology company in the healthcare sector trading on NYSE, led by CEO Maria L. Maccecchini, with a market cap of $57.6M.
Market Cap$57.6M
Employees6.0
CEOMaria L. Maccecchini
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Annovis Bio FAQ
Common questions about Annovis Bio
Annovis Bio is scheduled to report earnings for Q1 2026 on May 12, 2026.
Annovis Bio has approximately 6 employees.